4
MARKET OVERVIEW
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Covers the key developments, trend analysis, and actionable insights to support strategic planning and positioning.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
THREAT OF SUBSTITUTES
5.1.3
BARGAINING POWER OF SUPPLIERS
5.1.4
BARGAINING POWER OF BUYERS
5.1.5
INTENSITY OF COMPETITION RIVALRY
5.2
MACROECONOMIC OUTLOOK
5.2.1
GDP TRENDS AND FORECAST
5.2.2
TRENDS IN EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
5.2.3
TRENDS IN EUROPE HEALTHCARE/PHARMA INDUSTRY
5.4.1
EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFTS
5.5.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022–2024)
5.5.2
AVERAGE SELLING PRICE TREND, BY COUNTRY (2022–2024)
5.6
TRADE ANALYSIS (2020–2024)
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10
IMPACT OF 2025 US TARIFF – EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON COUNTRIES/REGIONS
5.10.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1.2
MAGNETIC-BEAD BASED TECHNOLOGY
6.1.3
AUTOMATED PLATFORMS
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.2
SAMPLE HOMOGENIZATION AND DISRUPTION SYSTEMS
6.3
ADJACENT TECHNOLOGIES
6.3.1
MICROFLUIDIC EXTRACTION
6.3.2
EXTRACTION-FREE AMPLIFICATION
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.3
CERTIFICATIONS, LABELING, & ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, (MARKET SIZE 2023 – 2030, FORECAST TO 2030 – IN VALUE, USD MILLION)
COMPARATIVE ASSESSMENT OF KEY PRODUCTS, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
9.3.1
AUTOMATIC INSTRUMENTS
10
EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2023–2030 (USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS, AND MARKET POTENTIAL ACROSS EACH TYPE
10.2
PLASMID DNA ISOLATION AND PURIFICATION
10.3
TOTAL RNA ISOLATION AND PURIFICATION
10.4
GENOMIC DNA ISOLATION AND PURIFICATION
10.5
MESSENGER RNA ISOLATION AND PURIFICATION
10.6
CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
10.7
MICRORNA ISOLATION AND PURIFICATION
11
EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2023–2030 (USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS, AND MARKET POTENTIAL ACROSS EACH METHOD
11.2
MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
11.3
REAGENT-BASED ISOLATION AND PURIFICATION
11.4
COLUMN-BASED ISOLATION AND PURIFICATION
12
EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS, AND MARKET POTENTIAL ACROSS EACH APPLICATION
12.3
DRUG DISCOVERY & DEVELOPMENT
12.4
PERSONALIZED MEDICINE
12.5
AGRICULTURE AND ANIMAL RESEARCH
13
EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2023–2030 (USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS, AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
13.2
HOSPITALS AND DIAGNOSTIC CENTERS
13.3
ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
13.4
PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
13.5
CONTRACT RESEARCH ORGANIZATIONS (CROS)
14
EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
ASSESSMENT OF GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY EUROPE REGIONS AND COUNTRIES
14.2.3
MACROECONOMIC OUTLOOK OF EUROPE
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
15.2
KEY PLAYERS STRATEGY/ RIGHT TO WIN
15.3
REVENUE ANALYSIS, 2022–2024
15.4
MARKET SHARE ANALYSIS,
15.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
15.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
15.5.5.1
COMPANY FOOTPRINT
15.5.5.2
REGION FOOTPRINT
15.5.5.3
PRODUCT FOOTPRINT
15.5.5.4
APPLICATION FOOTPRINT
15.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
15.6.1
PROGRESSIVE COMPANIES
15.6.2
RESPONSIVE COMPANIES
15.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
15.6.5.1
DETAILED LIST OF KEY STARTUPS/ SMES
15.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
15.8
VALUATION AND FINANCIAL METRICS
15.9
COMPETITIVE SCENARIO
15.9.3
OTHER DEVELOPMENTS
16.1.1THERMO FISHER SCIENTIFIC, INC.
16.1.2
DANAHER CORPORATION
16.1.5
F. HOFFMAN-LA ROCHE LTD.
16.1.6
AGILENT TECHNOLOGIES
16.1.8
LGC BIOSEARCH TECHNOLOGIES
NOTE: THE DETAILS ON BUSINESS OVERVIEW, FINANCIAL INFORMATION, PRODUCT PORTFOLIO, RECENT DEVELOPMENTS, AND MARKETSANDMARKETS VIEW WILL BE PROVIDED FOR ~25 COMPANIES. THESE DETAILS MIGHT NOT BE CAPTURED IN THE CASE OF UNLISTED COMPANIES. THE PROVIDED LIST
17.1.1.1
KEY SOURCES OF SECONDARY DATA
17.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
17.1.2.1
BREAKDOWN OF PRIMARIES
17.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
17.2
MARKET SIZE ESTIMATION
17.2.1
EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SIZE ESTIMATION
17.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
17.2.1.2
MNM REPOSITORY ANALYSIS
17.2.1.3
SECONDARY ANALYSIS
17.2.1.4
PRIMARY RESEARCH
17.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
17.2.2
SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH)
17.3
MARKET GROWTH RATE PROJECTIONS
17.6
RESEARCH ASSUMPTIONS
17.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3
AVAILABLE CUSTOMIZATIONS
Growth opportunities and latent adjacency in Europe Nucleic Acid Isolation and Purification Market